Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ALGN's Cash to Debt is ranked higher than
100% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. ALGN: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ALGN' s Cash to Debt Range Over the Past 10 Years
Min: 5.57  Med: No Debt Max: No Debt
Current: No Debt
Equity to Asset 0.72
ALGN's Equity to Asset is ranked higher than
65% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. ALGN: 0.72 )
Ranked among companies with meaningful Equity to Asset only.
ALGN' s Equity to Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.76 Max: 0.89
Current: 0.72
0.55
0.89
Interest Coverage 120.24
ALGN's Interest Coverage is ranked higher than
55% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 71.73 vs. ALGN: 120.24 )
Ranked among companies with meaningful Interest Coverage only.
ALGN' s Interest Coverage Range Over the Past 10 Years
Min: 98.99  Med: 7703.53 Max: No Debt
Current: 120.24
F-Score: 6
Z-Score: 13.83
M-Score: -2.21
WACC vs ROIC
11.21%
56.76%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 23.59
ALGN's Operating margin (%) is ranked higher than
93% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. ALGN: 23.59 )
Ranked among companies with meaningful Operating margin (%) only.
ALGN' s Operating margin (%) Range Over the Past 10 Years
Min: -18.19  Med: 14.78 Max: 26.54
Current: 23.59
-18.19
26.54
Net-margin (%) 18.78
ALGN's Net-margin (%) is ranked higher than
91% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 2.25 vs. ALGN: 18.78 )
Ranked among companies with meaningful Net-margin (%) only.
ALGN' s Net-margin (%) Range Over the Past 10 Years
Min: -16.94  Med: 13.24 Max: 26.31
Current: 18.78
-16.94
26.31
ROE (%) 21.60
ALGN's ROE (%) is ranked higher than
90% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 1.47 vs. ALGN: 21.60 )
Ranked among companies with meaningful ROE (%) only.
ALGN' s ROE (%) Range Over the Past 10 Years
Min: -39.51  Med: 16.68 Max: 42.13
Current: 21.6
-39.51
42.13
ROA (%) 15.76
ALGN's ROA (%) is ranked higher than
93% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.44 vs. ALGN: 15.76 )
Ranked among companies with meaningful ROA (%) only.
ALGN' s ROA (%) Range Over the Past 10 Years
Min: -23.81  Med: 12.64 Max: 31.86
Current: 15.76
-23.81
31.86
ROC (Joel Greenblatt) (%) 162.18
ALGN's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 4.32 vs. ALGN: 162.18 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ALGN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -126.9  Med: 135.69 Max: 369.18
Current: 162.18
-126.9
369.18
Revenue Growth (3Y)(%) 15.40
ALGN's Revenue Growth (3Y)(%) is ranked higher than
85% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. ALGN: 15.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ALGN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.6  Med: 15.4 Max: 146.7
Current: 15.4
7.6
146.7
EBITDA Growth (3Y)(%) 26.70
ALGN's EBITDA Growth (3Y)(%) is ranked higher than
83% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 2.80 vs. ALGN: 26.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ALGN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -35.3  Med: 24.2 Max: 45.2
Current: 26.7
-35.3
45.2
EPS Growth (3Y)(%) 35.60
ALGN's EPS Growth (3Y)(%) is ranked higher than
83% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. ALGN: 35.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ALGN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -76.1  Med: 16.3 Max: 289.3
Current: 35.6
-76.1
289.3
GuruFocus has detected 3 Warning Signs with Align Technology Inc $ALGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ALGN's 10-Y Financials

Financials (Next Earnings Date: 2017-01-31)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ALGN Guru Trades in Q1 2016

John Hussman 43,000 sh (New)
RS Investment Management 569,189 sh (+83.43%)
Jim Simons 700,807 sh (+14.09%)
Columbia Wanger 3,075,617 sh (+4.53%)
Ken Fisher 113,581 sh (+1.61%)
Ron Baron 27,500 sh (unchged)
Paul Tudor Jones Sold Out
Pioneer Investments 336,601 sh (-16.13%)
Mario Gabelli 5,000 sh (-16.67%)
Mariko Gordon 58,382 sh (-20.26%)
Ruane Cunniff 54,433 sh (-20.64%)
Steven Cohen 17,800 sh (-85.53%)
» More
Q2 2016

ALGN Guru Trades in Q2 2016

Joel Greenblatt 15,104 sh (New)
Paul Tudor Jones 5,745 sh (New)
Steven Cohen 50,600 sh (+184.27%)
Jim Simons 839,200 sh (+19.75%)
RS Investment Management 601,734 sh (+5.72%)
Ken Fisher 116,266 sh (+2.36%)
Mario Gabelli 5,000 sh (unchged)
John Hussman 43,000 sh (unchged)
Ron Baron 26,640 sh (-3.13%)
Pioneer Investments 318,435 sh (-5.40%)
Ruane Cunniff 48,123 sh (-11.59%)
Columbia Wanger 2,393,012 sh (-22.19%)
Mariko Gordon 42,420 sh (-27.34%)
» More
Q3 2016

ALGN Guru Trades in Q3 2016

George Soros 2,515 sh (New)
Steve Mandel 2,436,920 sh (New)
Jim Simons 944,200 sh (+12.51%)
Ron Baron 26,640 sh (unchged)
Ruane Cunniff 48,123 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones 5,700 sh (-0.78%)
Ken Fisher 109,455 sh (-5.86%)
Pioneer Investments 278,266 sh (-12.61%)
Mario Gabelli 4,000 sh (-20.00%)
Mariko Gordon 30,286 sh (-28.60%)
Columbia Wanger 1,614,224 sh (-32.54%)
Steven Cohen 25,300 sh (-50.00%)
Joel Greenblatt 2,504 sh (-83.42%)
» More
Q4 2016

ALGN Guru Trades in Q4 2016

Ken Fisher 102,242 sh (-6.59%)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NYSE:TFX, OTCPK:SONVY, NYSE:VAR, OTCPK:CHEOY, NAS:ABMD, OTCPK:WILLF, NAS:NUVA, OTCPK:EKTAY, NAS:MASI, NAS:IART, NYSE:GMED, NAS:WMGI, NYSE:NVRO, NAS:LIVN, NYSE:PEN, OTCPK:NHNKY, OTCPK:SNNUF, NAS:ZLTQ, NAS:INGN, OTCPK:IOBCF » details
Traded in other countries:AFW.Germany,
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage.

Align Technology Inc was incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner and Scanners and Services. The Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanners and Services segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company distributes its products directly to its customers: orthodontists and general practitioner dentists as well as to restorative dentists, including prosthodontists, periodontists, and oral surgeons. The Company's manufacturing facilities are located in Juarez, Mexico, where it conducts its aligner fabrication, distribute and repair its scanners, perform its CAD/CAM services, and in Or Yehuda, Israel where it produce its handheld intra-oral scanner wand. Its trademarks include Invisalign, Align, ClinCheck, Invisalign Assist, Invisalign Teen, Vivera, SmartForce, SmartTrack, Power Ridge and iTero. The Company competes with Danaher Corporation, 3M, Sirona Dental Systems, Inc., Dentsply International, Inc. and among others. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.

Top Ranked Articles about Align Technology Inc

Most-Bought Small Cap Stocks During 4th Quarter 4 smaller companies popular among the gurus
Small cap companies are generally defined as those with capitalizations between $300 million and $2 billion. While these smaller companies tend to present more risk and volatility than larger stocks, they also have a chance of higher returns and tend to have much less coverage from analysts and the media. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 40.58
ALGN's P/E(ttm) is ranked lower than
69% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 26.07 vs. ALGN: 40.58 )
Ranked among companies with meaningful P/E(ttm) only.
ALGN' s P/E(ttm) Range Over the Past 10 Years
Min: 5.57  Med: 32.25 Max: 222.88
Current: 40.58
5.57
222.88
Forward P/E 31.06
ALGN's Forward P/E is ranked lower than
70% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 24.39 vs. ALGN: 31.06 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 40.58
ALGN's PE(NRI) is ranked lower than
68% of the 173 Companies
in the Global Medical Devices industry.

( Industry Median: 25.71 vs. ALGN: 40.58 )
Ranked among companies with meaningful PE(NRI) only.
ALGN' s PE(NRI) Range Over the Past 10 Years
Min: 5.57  Med: 32.25 Max: 222.88
Current: 40.58
5.57
222.88
Price/Owner Earnings (ttm) 54.15
ALGN's Price/Owner Earnings (ttm) is ranked lower than
73% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 31.72 vs. ALGN: 54.15 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ALGN' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.35  Med: 31.17 Max: 895
Current: 54.15
5.35
895
P/B 7.82
ALGN's P/B is ranked lower than
80% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. ALGN: 7.82 )
Ranked among companies with meaningful P/B only.
ALGN' s P/B Range Over the Past 10 Years
Min: 1.86  Med: 5.2 Max: 15.87
Current: 7.82
1.86
15.87
P/S 7.62
ALGN's P/S is ranked lower than
81% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 3.08 vs. ALGN: 7.62 )
Ranked among companies with meaningful P/S only.
ALGN' s P/S Range Over the Past 10 Years
Min: 1.3  Med: 4.48 Max: 8.22
Current: 7.62
1.3
8.22
PFCF 44.89
ALGN's PFCF is ranked lower than
70% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. ALGN: 44.89 )
Ranked among companies with meaningful PFCF only.
ALGN' s PFCF Range Over the Past 10 Years
Min: 10.89  Med: 23.21 Max: 47.64
Current: 44.89
10.89
47.64
POCF 31.57
ALGN's POCF is ranked lower than
72% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 18.89 vs. ALGN: 31.57 )
Ranked among companies with meaningful POCF only.
ALGN' s POCF Range Over the Past 10 Years
Min: 8.19  Med: 19.88 Max: 361.07
Current: 31.57
8.19
361.07
EV-to-EBIT 29.12
ALGN's EV-to-EBIT is ranked lower than
61% of the 166 Companies
in the Global Medical Devices industry.

( Industry Median: 21.95 vs. ALGN: 29.12 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -378.4  Med: 21.8 Max: 157.9
Current: 29.12
-378.4
157.9
EV-to-EBITDA 26.70
ALGN's EV-to-EBITDA is ranked lower than
71% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 16.63 vs. ALGN: 26.70 )
Ranked among companies with meaningful EV-to-EBITDA only.
ALGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.4  Med: 19.55 Max: 578.7
Current: 26.7
-248.4
578.7
PEG 2.88
ALGN's PEG is ranked lower than
58% of the 74 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. ALGN: 2.88 )
Ranked among companies with meaningful PEG only.
ALGN' s PEG Range Over the Past 10 Years
Min: 1.33  Med: 1.75 Max: 2.88
Current: 2.88
1.33
2.88
Shiller P/E 93.08
ALGN's Shiller P/E is ranked lower than
83% of the 48 Companies
in the Global Medical Devices industry.

( Industry Median: 48.71 vs. ALGN: 93.08 )
Ranked among companies with meaningful Shiller P/E only.
ALGN' s Shiller P/E Range Over the Past 10 Years
Min: 73.35  Med: 98.1 Max: 680.5
Current: 93.08
73.35
680.5
Current Ratio 2.66
ALGN's Current Ratio is ranked higher than
54% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. ALGN: 2.66 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 2.96 Max: 6.96
Current: 2.66
1.59
6.96
Quick Ratio 2.58
ALGN's Quick Ratio is ranked higher than
64% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. ALGN: 2.58 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s Quick Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.9 Max: 6.82
Current: 2.58
1.55
6.82
Days Inventory 32.34
ALGN's Days Inventory is ranked higher than
92% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 131.45 vs. ALGN: 32.34 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s Days Inventory Range Over the Past 10 Years
Min: 9.28  Med: 17.68 Max: 32.75
Current: 32.34
9.28
32.75
Days Sales Outstanding 87.93
ALGN's Days Sales Outstanding is ranked lower than
65% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 67.65 vs. ALGN: 87.93 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.57  Med: 62.74 Max: 87.93
Current: 87.93
57.57
87.93
Days Payable 48.51
ALGN's Days Payable is ranked lower than
55% of the 253 Companies
in the Global Medical Devices industry.

( Industry Median: 56.36 vs. ALGN: 48.51 )
Ranked among companies with meaningful Days Payable only.
ALGN' s Days Payable Range Over the Past 10 Years
Min: 25.83  Med: 46.94 Max: 85.64
Current: 48.51
25.83
85.64

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.50
ALGN's 3-Year Average Share Buyback Ratio is ranked higher than
86% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. ALGN: 0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ALGN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -139.2  Med: -3.5 Max: 0.5
Current: 0.5
-139.2
0.5

Valuation & Return

vs
industry
vs
history
Price/Net Cash 33.69
ALGN's Price/Net Cash is ranked lower than
69% of the 101 Companies
in the Global Medical Devices industry.

( Industry Median: 17.13 vs. ALGN: 33.69 )
Ranked among companies with meaningful Price/Net Cash only.
ALGN' s Price/Net Cash Range Over the Past 10 Years
Min: 1.73  Med: 20.69 Max: 417
Current: 33.69
1.73
417
Price/Net Current Asset Value 14.49
ALGN's Price/Net Current Asset Value is ranked lower than
74% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 6.60 vs. ALGN: 14.49 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ALGN' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.35  Med: 8.9 Max: 25.8
Current: 14.49
1.35
25.8
Price/Tangible Book 8.56
ALGN's Price/Tangible Book is ranked lower than
74% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 4.35 vs. ALGN: 8.56 )
Ranked among companies with meaningful Price/Tangible Book only.
ALGN' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.91  Med: 6.1 Max: 16.46
Current: 8.56
0.91
16.46
Price/Projected FCF 2.69
ALGN's Price/Projected FCF is ranked lower than
64% of the 126 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. ALGN: 2.69 )
Ranked among companies with meaningful Price/Projected FCF only.
ALGN' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.38  Med: 2.2 Max: 14.5
Current: 2.69
1.38
14.5
Price/Median PS Value 1.70
ALGN's Price/Median PS Value is ranked lower than
84% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. ALGN: 1.70 )
Ranked among companies with meaningful Price/Median PS Value only.
ALGN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.4  Med: 0.95 Max: 7.11
Current: 1.7
0.4
7.11
Price/Peter Lynch Fair Value 1.62
ALGN's Price/Peter Lynch Fair Value is ranked lower than
51% of the 51 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. ALGN: 1.62 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ALGN' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.57  Med: 1.98 Max: 14.72
Current: 1.62
0.57
14.72
Price/Graham Number 3.93
ALGN's Price/Graham Number is ranked lower than
72% of the 138 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. ALGN: 3.93 )
Ranked among companies with meaningful Price/Graham Number only.
ALGN' s Price/Graham Number Range Over the Past 10 Years
Min: 0.85  Med: 3.09 Max: 17.76
Current: 3.93
0.85
17.76
Earnings Yield (Greenblatt) (%) 3.42
ALGN's Earnings Yield (Greenblatt) (%) is ranked higher than
68% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. ALGN: 3.42 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ALGN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.6  Med: 4.2 Max: 9.7
Current: 3.42
0.6
9.7
Forward Rate of Return (Yacktman) (%) 29.22
ALGN's Forward Rate of Return (Yacktman) (%) is ranked higher than
93% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. ALGN: 29.22 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ALGN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -5.8  Med: 2.6 Max: 29.5
Current: 29.22
-5.8
29.5

More Statistics

Revenue (TTM) (Mil) $1,017
EPS (TTM) $ 2.35
Beta1.18
Short Percentage of Float5.68%
52-Week Range $57.31 - 102.10
Shares Outstanding (Mil)79.69

Analyst Estimate

Dec16 Dec17
Revenue (Mil $) 1,078 1,285
EPS ($) 2.25 3.09
EPS w/o NRI ($) 2.25 3.09
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
6 Stocks That Are Beating the Market Oct 11 2016 
Most-Bought Small Cap Stocks During 4th Quarter Mar 28 2016 
Align Technology – Can It Align Your Portfolio to Smile? Mar 18 2016 
Ruane Cunniff's Top New Buys of 3rd Quarter Dec 15 2015 
Valeant Top Shareholder Sequoia Fund's Largest New Buys Nov 19 2015 
Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
WEEKLY CFO SELLS HIGHLIGHT: CY, UTEK, STJ, ALGN, TXN, JAH, YUM May 01 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 
Weekly CEO Sells Highlight: Rockwell Automation Inc. Common, Penske Automotive Group Inc., Align Tec Feb 07 2010 
Align Technology Inc. (ALGN) President and CEO Thomas M Prescott sells 328,596 Shares Feb 03 2010 

More From Other Websites
Align Poised On Global Expansion & Invisalign Teen Growth Jan 11 2017
Align Technology, Inc. – Value Analysis (NASDAQ:ALGN) : January 10, 2017 Jan 10 2017
Illumina (ILMN) Launches NovaSeq Series for $100 Genome Jan 10 2017
QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite Jan 10 2017
Align Technology Appoints Lynn Pendergrass to Newly Created Role of Vice President of the Americas... Jan 09 2017
LLabCorp: Reimbursement Scenario a Drag Amid Other Woes Jan 09 2017
Align Technology, Inc. breached its 50 day moving average in a Bearish Manner : ALGN-US : January 9,... Jan 09 2017
ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders Jan 09 2017
Myriad Genetics: Evidence Street Reviews EndoPredict Test Jan 06 2017
Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View Jan 05 2017
Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite Jan 05 2017
Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging Jan 05 2017
ResMed Achieves Key Milestone in Sleep-Disordered Breathing Jan 05 2017
Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay Jan 04 2017
Align Technology to Announce Fourth Quarter and Fiscal Year 2016 Results on January 31, 2017 Jan 03 2017
Align Technology to Announce Fourth Quarter and Fiscal Year 2016 Results on January 31, 2017 Jan 03 2017
Illumina Fettered With Losses: Can It Bounce Back in 2017? Jan 03 2017
Masimo to Launch Advanced Monitoring Technologies in India Jan 03 2017
OPKO Health (OPK) Reports Failure in hGH-CTP Phase 3 Jan 02 2017
Abaxis (ABAX) Veterinary Prospects Bright: Should You Hold? Jan 02 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)